(“Early Equity” or “the Company”)
Issue of Equity
The Company incurred expenses in connection with the Subscription of £5,264.70 which have been settled by the issue of 1,052,940 new ordinary shares of 0.1p.
As a result the Company has issued a total of 22,111,740 new ordinary shares and application will be made for them to be admitted to trading on AQSE, which is expected to be on or around 24 November 2020.
The new ordinary shares will rank pari passu with the existing ordinary shares of the Company. Following the issue of the new ordinary shares, the Company’s issued share capital will comprise 980,226,524 ordinary shares of 0.1p (including the 22,111,740 new ordinary shares).
The above figure of 980,226,524 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the
This announcement contains information which, prior to its disclosure, was inside information for the purposes of Article 7 of EU Regulation 596/2014.
The directors of
Tel: +44 (0)7830 182501
AQSE Corporate Adviser
Tel: +44 (0)207 399 9400